Search

Your search keyword '"Schlichting E."' showing total 379 results

Search Constraints

Start Over You searched for: Author "Schlichting E." Remove constraint Author: "Schlichting E."
379 results on '"Schlichting E."'

Search Results

1. Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)

7. AXSANA – AXillary Surgery After NeoAdjuvant Treatment (EUBREAST-3): current status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

9. Retreatment of previously treated intracranial aneurysm: Procedural complications and risk factors for complications

10. DNA copy number motifs are strong and independent predictors of survival in breast cancer

11. Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer – a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

14. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

15. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

16. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.

17. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

18. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

20. Two truncating variants in FANCC and breast cancer risk

21. Two truncating variants in FANCC and breast cancer risk

22. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

23. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

26. 25th Congress of the European Society for Pediatric Neurosurgery (ESPN) Paris-France, 8-11 May 2016

28. Abstract P6-07-01: A translational and five-year clinical update in patients treated with neoadjuvant chemotherapy randomized to bevacizumab or control in HER2 negative breast cancer

36. Abstract P6-13-01: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - A randomized phase II study

37. Abstract P2-05-16: Establishment of molecular profiling for individual treatment decisions in early breast cancer – Clinical impact of PAM50 and PAM50 risk of recurrence score after more than 16 years follow up

46. Abstract P4-14-02: Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - A randomized phase II study

Catalog

Books, media, physical & digital resources